Business Description
Race Oncology Ltd
ISIN : AU000000RAC3
Description
Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -32.1 | |||||
| 3-Year EPS without NRI Growth Rate | -19.9 | |||||
| 3-Year FCF Growth Rate | -42.1 | |||||
| 3-Year Book Growth Rate | 47.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.57 | |||||
| 9-Day RSI | 64.48 | |||||
| 14-Day RSI | 61.83 | |||||
| 6-1 Month Momentum % | 36.31 | |||||
| 12-1 Month Momentum % | -14.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 28.35 | |||||
| Quick Ratio | 28.35 | |||||
| Cash Ratio | 21.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.9 | |||||
| Shareholder Yield % | -0.11 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -43.73 | |||||
| ROA % | -42.28 | |||||
| ROIC % | -349.69 | |||||
| ROC (Joel Greenblatt) % | -728.29 | |||||
| ROCE % | -69.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 12.91 | |||||
| Price-to-Tangible-Book | 14.27 | |||||
| EV-to-EBIT | -14.46 | |||||
| EV-to-EBITDA | -14.7 | |||||
| EV-to-FCF | -20.57 | |||||
| Price-to-Net-Current-Asset-Value | 14.27 | |||||
| Price-to-Net-Cash | 19.63 | |||||
| Earnings Yield (Greenblatt) % | -6.92 | |||||
| FCF Yield % | -4.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Race Oncology Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.069 | ||
| Beta | 1.16 | ||
| Volatility % | 90.94 | ||
| 14-Day RSI | 61.83 | ||
| 14-Day ATR (A$) | 0.0948 | ||
| 20-Day SMA (A$) | 1.49075 | ||
| 12-1 Month Momentum % | -14.08 | ||
| 52-Week Range (A$) | 0.64 - 1.81 | ||
| Shares Outstanding (Mil) | 169.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Race Oncology Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Race Oncology Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Race Oncology Ltd Frequently Asked Questions
What is Race Oncology Ltd(ASX:RAC)'s stock price today?
The current price of ASX:RAC is A$1.57. The 52 week high of ASX:RAC is A$1.81 and 52 week low is A$0.64.
When is next earnings date of Race Oncology Ltd(ASX:RAC)?
The next earnings date of Race Oncology Ltd(ASX:RAC) is .
Does Race Oncology Ltd(ASX:RAC) pay dividends? If so, how much?
Race Oncology Ltd(ASX:RAC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers